Valendo Health, a diabetes-focused, value-based endocrinology company, announced its launch with $4 million in seed funding and two providers.
The company, built out of Redesign Health, aims to increase revenue for endocrinologists while assisting with the transition to a value-based care model.
It offers telehealth and remote patient monitoring services with diabetes care clinicians, an...
